Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Opaganib by RedHill Biopharma for Solid Tumor: Likelihood of Approval
Opaganib is under clinical development by RedHill Biopharma and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Opaganib by RedHill Biopharma for Colorectal Cancer: Likelihood of Approval
Opaganib is under clinical development by RedHill Biopharma and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
Opaganib by RedHill Biopharma for Pancreatic Cancer: Likelihood of Approval
Opaganib is under clinical development by RedHill Biopharma and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Opaganib by RedHill Biopharma for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Opaganib is under clinical development by RedHill Biopharma and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to...